These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9422091)

  • 1. Affinity of antibodies to MUC1 antigens.
    Karanikas V; Patton K; Jamieson G; Pietersz G; McKenzie I
    Tumour Biol; 1998; 19 Suppl 1():71-8. PubMed ID: 9422091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17-23, 1996.
    Price MR; Rye PD; Petrakou E; Murray A; Brady K; Imai S; Haga S; Kiyozuka Y; Schol D; Meulenbroek MF; Snijdewint FG; von Mensdorff-Pouilly S; Verstraeten RA; Kenemans P; Blockzjil A; Nilsson K; Nilsson O; Reddish M; Suresh MR; Koganty RR; Fortier S; Baronic L; Berg A; Longenecker MB; Hilgers J
    Tumour Biol; 1998; 19 Suppl 1():1-20. PubMed ID: 9422084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of desialylation on binding, affinity, and specificity of 56 monoclonal antibodies against MUC1 mucin.
    Dai J; Allard WJ; Davis G; Yeung KK
    Tumour Biol; 1998; 19 Suppl 1():100-10. PubMed ID: 9422094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the role of type 1 core O-glycans in the binding of anti-MUC1 antibodies by cytofluorometry and synthetic peptide/glycopeptide binding inhibition studies.
    Reddish MA; Suresh MR; Koganty RR; Fortier S; Baronic L; Berg A; Longenecker BM
    Tumour Biol; 1998; 19 Suppl 1():57-66. PubMed ID: 9422089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of carbohydrate specificity of monoclonal antibodies against MUC1.
    Galanina OE; Simeoni LA; Ter-Grigoryan AG; Belyanchikov IM; Bovin NV
    Tumour Biol; 1998; 19 Suppl 1():79-87. PubMed ID: 9422092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope characterization of MUC1 antibodies.
    Imai S; Haga S; Kiyozuka Y
    Tumour Biol; 1998; 19 Suppl 1():30-4. PubMed ID: 9422086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of glycosylation of a synthetic MUC1 mucin-core-related peptide on recognition by anti-mucin antibodies.
    Spencer DI; Price MR; Tendler SJ; De Matteis CI; Stadie T; Hanisch FG
    Cancer Lett; 1996 Feb; 100(1-2):11-5. PubMed ID: 8620429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope characterization of MUC1 antibodies.
    Blockzjil A; Nilsson K; Nilsson O
    Tumour Biol; 1998; 19 Suppl 1():46-56. PubMed ID: 9422088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosylation of MUC1 influences the binding of a therapeutic antibody by altering the conformational equilibrium of the antigen.
    Movahedin M; Brooks TM; Supekar NT; Gokanapudi N; Boons GJ; Brooks CL
    Glycobiology; 2017 Jul; 27(7):677-687. PubMed ID: 28025250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope mapping of anti-MUC1 mucin protein core monoclonal antibodies.
    Petrakou E; Murray A; Price MR
    Tumour Biol; 1998; 19 Suppl 1():21-9. PubMed ID: 9422085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proceedings of the International Society for Oncodevelopmental Biology and Medicine (ISOBM) TD-4 International Workshop on Monoclonal Antibodies against MUC1. San Diego, California, November 17-23, 1996.
    Tumour Biol; 1998; 19 Suppl 1():1-152. PubMed ID: 9441368
    [No Abstract]   [Full Text] [Related]  

  • 12. Structural and dynamic consequences of increasing repeats in a MUC1 peptide tumor antigen.
    Schuman JT; Grinstead JS; Apostolopoulos V; Campbell AP
    Biopolymers; 2005 Feb; 77(2):107-20. PubMed ID: 15635690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope mapping of antigenic MUC1 peptides to breast cancer antibody fragment B27.29: a heteronuclear NMR study.
    Grinstead JS; Schuman JT; Campbell AP
    Biochemistry; 2003 Dec; 42(48):14293-305. PubMed ID: 14640698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cells recognize PD(N/T)R motif common in a variable number of tandem repeat and degenerate repeat sequences of MUC1.
    Pisarev VM; Kinarsky L; Caffrey T; Hanisch FG; Sanderson S; Hollingsworth MA; Sherman S
    Int Immunopharmacol; 2005 Feb; 5(2):315-30. PubMed ID: 15652762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human single-chain Fv antibodies to MUC1 core peptide selected from phage display libraries recognize unique epitopes and predominantly bind adenocarcinoma.
    Henderikx P; Kandilogiannaki M; Petrarca C; von Mensdorff-Pouilly S; Hilgers JH; Krambovitis E; Arends JW; Hoogenboom HR
    Cancer Res; 1998 Oct; 58(19):4324-32. PubMed ID: 9766660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A straightforward protocol for the preparation of high performance microarray displaying synthetic MUC1 glycopeptides.
    Matsushita T; Takada W; Igarashi K; Naruchi K; Miyoshi R; Garcia-Martin F; Amano M; Hinou H; Nishimura S
    Biochim Biophys Acta; 2014 Mar; 1840(3):1105-16. PubMed ID: 24246952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of novel recombinant single-domain antibodies against tandem repeat region of MUC1 mucin.
    Rahbarizadeh F; Rasaee MJ; Forouzandeh Moghadam M; Allameh AA; Sadroddiny E
    Hybrid Hybridomics; 2004 Jun; 23(3):151-9. PubMed ID: 15312305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of monoclonal antibodies by epitope and mimotope affinity chromatography.
    Murray A; Sekowski M; Spencer DI; Denton G; Price MR
    J Chromatogr A; 1997 Oct; 782(1):49-54. PubMed ID: 9368405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a panel of monoclonal antibodies using GalNAc glycosylated peptides and recombinant MUC1.
    Reis CA; Hassan H; Bennett EP; Clausen H
    Tumour Biol; 1998; 19 Suppl 1():127-33. PubMed ID: 9422098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope specificity of 30 monoclonal antibodies against cytokeratin antigens: the ISOBM TD5-1 Workshop.
    Stigbrand T; Andrés C; Bellanger L; Bishr Omary M; Bodenmüller H; Bonfrer H; Brundell J; Einarsson R; Erlandsson A; Johansson A; Leca JF; Levi M; Meier T; Nap M; Nustad K; Seguin P; Sjödin A; Sundström B; van Dalen A; Wiebelhaus E; Wiklund B; Arlestig L; Hilgers J
    Tumour Biol; 1998; 19(2):132-52. PubMed ID: 9486565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.